Literature DB >> 33911319

Role of heat-shock proteins in infection of human adenocarcinoma cell line MCF-7 by tumor-adapted rotavirus isolates.

Claudia Perez1, José Rico1, Carlos Guerrero1, Orlando Acosta1.   

Abstract

BACKGROUND: Viruses are being used as alternative and complementary tools for treating cancers. Oncolytic viruses exhibit tumor tropism, ability to enhance anti-tumor immunity and ability to be used in combination with conventional chemotherapy and radiotherapy. We have recently selected some rotavirus isolates which are adapted to efficiently infect and kill tumor cell lines. AIM: We tested five tumor cell-adapted rotavirus isolates for their ability to infect the human adenocarcinoma cell line MCF-7.
METHODS: Cell surface membrane-associated proteins mediating virus particle attachment were characterized using ELISA, immunoprecipitation, FACS analysis, and antibody blocking.
RESULTS: It was found that heat shock proteins (HSPs) such as Hsp90, Hsp70, Hsp60, and Hsp40 are expressed on the cell surface forming complexes with protein disulfide isomerase (PDI), integrin β3, and heat shock cognate protein 70 (Hsc70) in lipid raft microdomains. Interaction of rotavirus isolates with these cellular proteins was further confirmed by a competition assay and an inhibition assay involving the HSPs tested.
CONCLUSION: Our findings suggest that the tumor cell-adapted rotavirus isolates studied here offer a promising tool for killing tumor cells, thus encouraging further research into this topic, including animal models.
Copyright © 2021 Colombia Medica.

Entities:  

Keywords:  MCF-7 cells; Oncolytic viruses; autophagic cell death; cancer vaccines; heat-shock proteins; integrins; oncolytic virotherapy; protein disulfide-isomerases; proto-oncogene proteins c-akt; pyroptosis; rotavirus; rotavirus infections

Mesh:

Substances:

Year:  2021        PMID: 33911319      PMCID: PMC8054709          DOI: 10.25100/cm.v51i4.4196

Source DB:  PubMed          Journal:  Colomb Med (Cali)        ISSN: 0120-8322


  40 in total

Review 1.  Adenovirus-based therapy for prostate cancer.

Authors:  Maria Ekblad; Gunnel Halldén
Journal:  Curr Opin Mol Ther       Date:  2010-08

2.  Quercetin-induced apoptosis in the monoblastoid cell line U937 in vitro and the regulation of heat shock proteins expression.

Authors:  Y Rong; E B Yang; K Zhang; P Mack
Journal:  Anticancer Res       Date:  2000 Nov-Dec       Impact factor: 2.480

Review 3.  Heat Shock Proteins Promote Cancer: It's a Protection Racket.

Authors:  Stuart K Calderwood; Jianlin Gong
Journal:  Trends Biochem Sci       Date:  2016-02-11       Impact factor: 13.807

Review 4.  Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors.

Authors:  Jonathan G Pol; Sarah Lévesque; Samuel T Workenhe; Shashi Gujar; Fabrice Le Boeuf; Derek R Clements; Jean-Eudes Fahrner; Laetitia Fend; John C Bell; Karen L Mossman; Jitka Fucikova; Radek Spisek; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2018-08-27       Impact factor: 8.110

5.  The peptide-binding and ATPase domains of recombinant hsc70 are required to interact with rotavirus and reduce its infectivity.

Authors:  Jimena Pérez-Vargas; Pedro Romero; Susana López; Carlos F Arias
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

6.  The molecular chaperone heat shock protein-90 positively regulates rotavirus infectionx.

Authors:  Dipanjan Dutta; Parikshit Bagchi; Arunachal Chatterjee; Mukti Kant Nayak; Anupam Mukherjee; Shiladitya Chattopadhyay; Shigeo Nagashima; Nobumichi Kobayashi; Satoshi Komoto; Koki Taniguchi; Mamta Chawla-Sarkar
Journal:  Virology       Date:  2009-07-22       Impact factor: 3.616

7.  Inhibition of archaeal growth and DNA topoisomerase VI activities by the Hsp90 inhibitor radicicol.

Authors:  D Gadelle; C Bocs; M Graille; P Forterre
Journal:  Nucleic Acids Res       Date:  2005-04-22       Impact factor: 16.971

Review 8.  Oncolytic Viruses-Interaction of Virus and Tumor Cells in the Battle to Eliminate Cancer.

Authors:  Anwen Howells; Giulia Marelli; Nicholas R Lemoine; Yaohe Wang
Journal:  Front Oncol       Date:  2017-09-08       Impact factor: 6.244

Review 9.  Oncolytic virotherapy as an immunotherapeutic strategy for multiple myeloma.

Authors:  Daniel E Meyers; Satbir Thakur; Chandini M Thirukkumaran; Don G Morris
Journal:  Blood Cancer J       Date:  2017-12-05       Impact factor: 11.037

Review 10.  Oncolytic Viruses in Cancer Treatment: A Review.

Authors:  Sean E Lawler; Maria-Carmela Speranza; Choi-Fong Cho; E Antonio Chiocca
Journal:  JAMA Oncol       Date:  2017-06-01       Impact factor: 31.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.